Flu & Dengue: Vaccination Campaigns & Health Updates from Bahía Blanca

Argentina is reinforcing its annual influenza vaccination campaign, initiating the second phase earlier than usual due to the circulation of new, more contagious strains of the virus. The proactive move, announced on March 21, 2026, aims to protect vulnerable populations before the onset of winter and the peak of influenza season. The Argentine Ministry of Health emphasizes the importance of timely vaccination to reduce severe complications, hospitalizations and mortality, particularly among high-risk groups.

Early Campaign Start Driven by Emerging Viral Strains

Dr. Maximiliano Núñez Fariña, Director of the Region Sanitaria 1, explained that the decision to advance the campaign was prompted by observations of the evolving epidemiological situation internationally. Specifically, a more contagious influenza strain has been gaining prominence in Europe and the Northern Hemisphere. As reported by La Nueva, provincial health ministers requested the national government to expedite the rollout to maximize immunization coverage before the arrival of colder weather.

Who is Prioritized for Vaccination?

The vaccination campaign is being rolled out in stages. The initial phase, which began on March 11, 2026, focuses on healthcare personnel and individuals aged 65 years and older. The second phase, starting March 23, expands eligibility to include pregnant women, postpartum individuals, and children between 6 months and 2 years of age. Individuals aged 2 to 64 with underlying health conditions are also eligible, but require a medical recommendation. The National Vaccination Calendar includes influenza vaccination for these specific groups.

Understanding Risk Factors

The influenza virus can lead to serious complications, including death, in certain populations. Those at higher risk include pregnant women, children under 5, adults over 65, and individuals with chronic medical conditions such as heart disease, respiratory illnesses, kidney disease, compromised immune systems, cancer, transplant recipients, obesity, and diabetes. The vaccine is designed to significantly reduce the likelihood of these severe outcomes.

Vaccine Availability and Distribution

The Ministry of Health has procured approximately 8 million doses of the influenza vaccine for nationwide distribution. Initial shipments arrived on March 8, enabling the commencement of the first phase. Further deliveries are expected in the coming weeks to support the continuation of the campaign. The distribution process involves sending doses from the national level to provinces, and then to regional health authorities.

Beyond Influenza: Vaccination Against Respiratory Syncytial Virus (RSV)

Alongside the influenza campaign, Argentina is also actively promoting vaccination against Respiratory Syncytial Virus (RSV). This vaccine is specifically recommended for pregnant women between weeks 32 and 36 of gestation. The goal is to protect newborns from bronchiolitis, a common and potentially severe respiratory illness in infants. While the RSV vaccine is available, coverage rates are currently below 30% as of early March 2026, highlighting a require for increased awareness and uptake.

Addressing Coverage Gaps and Public Health Concerns

While vaccination rates are generally good among healthcare workers and older adults, coverage tends to be lower in other priority groups, particularly pregnant women and young children. Health officials are implementing strategies to address these gaps and improve overall immunization rates. This includes targeted outreach and education efforts to emphasize the importance of vaccination for these vulnerable populations.

The Importance of Continued Surveillance

Alongside vaccination efforts, ongoing surveillance of influenza and other respiratory viruses is crucial for monitoring trends, detecting emerging strains, and informing public health responses. This includes tracking cases, analyzing viral characteristics, and assessing the effectiveness of vaccines. The Argentine health system is actively engaged in these surveillance activities to ensure a proactive and informed approach to respiratory disease prevention and control.

Looking Ahead: Maintaining Momentum and Addressing Emerging Challenges

The success of the influenza vaccination campaign relies on continued efforts to ensure vaccine availability, promote awareness, and address barriers to access. Regular evaluation of coverage rates and identification of areas for improvement are essential. Ongoing monitoring of the evolving epidemiological landscape, including the emergence of new viral strains, will be critical for adapting vaccination strategies and protecting the health of the Argentine population. The Ministry of Health will continue to provide updates and guidance as the situation evolves, and individuals are encouraged to consult with their healthcare providers for personalized recommendations.